about
Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancerChemotherapy of ovarian cancer in elderly patientsThe Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive LifeAn Immunohistochemical Algorithm for Ovarian Carcinoma Typing.Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer TherapyType-specific cell line models for type-specific ovarian cancer researchKallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft modelAssessing the genetic architecture of epithelial ovarian cancer histological subtypes.Cancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis.The preclinical natural history of serous ovarian cancer: defining the target for early detectionHER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.Ovarian cyst fluid of serous ovarian tumors contains large quantities of the brain amino acid N-acetylaspartate.Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells.A rare case of synchronous right ovarian clear cell carcinoma and an incidental left ovarian endometrioid carcinoma with immunohistochemical studyCoordinate patterns of estrogen receptor, progesterone receptor, and Wilms tumor 1 expression in the histopathologic distinction of ovarian from endometrial serous adenocarcinomasTherapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancerAdenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker.Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinomaNovel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.Targeted ovarian cancer treatment: the TRAILs of resistance.Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.Oral contraceptives decrease the prevalence of ovarian cancer in the henThe promise and challenge of ovarian cancer models.The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy.Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.Modulation of estrogenic action in clear cell carcinoma of the ovary (Review).RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation.Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health StudyEpithelial ovarian tumors: Clinicopathological correlation and immunohistochemical study.
P2860
Q24307419-B11A8C32-F0D9-48F3-A6DF-B71AC61A849EQ26771397-C01CE55C-197A-4EE5-9CEE-D94983DFBCACQ26785614-35FB50ED-0F61-4874-BA2C-F3819C7C0F25Q27313766-54BFD2B1-13CB-4CE8-BD37-A54B003192AAQ28084568-A2625F8D-F44E-42CB-BE00-C508C85009BFQ28536689-C957268F-67A5-460E-AB27-F04D3C73D261Q28742738-CD01634D-75BE-4198-A1C6-87A66606C238Q30276986-97AB7170-6F9B-4EBF-9E8E-B95F5D987896Q30418500-B4B36943-A7CC-4C1E-8EF8-E68EB6EE2FFCQ33487678-61D58A54-9773-43F3-A49C-F935349B06CBQ33517907-A75EF407-6AA2-485A-956D-5E190A517B9DQ33565482-484C9CC9-FC44-4C17-92F5-CDE65B28197AQ33645478-53DB9D18-5595-4BCC-9636-5E328D9DE5A9Q33809217-D0F49062-B782-4EB5-9521-A61AA03E5A21Q33837822-CED1804F-AC7D-4E46-9E01-6A98536BA198Q33992114-1369F0A9-1AF6-471E-BCDE-D8C18C584D6FQ34291894-927B0997-2EFF-4843-AF58-AE1F962105FDQ34397197-DFF81AF6-B579-4564-953B-41804CF4C67FQ34528553-613D6D50-C822-4CF9-9AEE-A538DE277042Q34579314-4F395312-B6D6-4232-AA40-E66F82F7E5C1Q34588329-DEA12A9C-A726-475E-A3AF-6661F0C359D3Q34738849-FB276932-671B-4E70-8C53-A569EEE69BC2Q34875061-96E7F9E9-0B92-4D3A-8735-044322196EBAQ35000449-B15699FA-68E5-4426-BA5C-71CB5AE78969Q35298842-FCA67B6A-3FD7-457B-99D9-24A82844BBADQ35609438-5F5A3E22-A987-4480-9CCE-485C633B032CQ35683375-7FB33752-EB79-480B-A3C5-997638DB841AQ35740147-7AE1980A-2640-4D1A-99F2-D0E916562B65Q35771750-8430BC85-C3ED-4D62-9C32-D0EE7BCD53CAQ35858991-E85171CE-3D73-4D76-8BDD-40EA6E4B7D69Q35872796-625E3920-4378-41D4-A777-34FAE4A7F6ABQ36089391-BA92F8D5-F2A8-424E-A19D-7469BFE09F37Q36157106-6860A39F-5B4A-4040-A674-C2DB22D58A44Q36213561-124EF0AF-BC90-4513-BE6B-9C986A041056Q36224720-EAA45086-D4D5-4F75-9FDA-8396F6AAF3A1Q36308299-DFB2FE40-1C85-4F47-88C3-7BA420DA8D16Q36354166-2C7B0828-C9C8-4D84-A78A-84A267D6BF8EQ36412660-0CFDBB11-B699-4035-BB80-3D06EE8DC947Q36421847-AB6E0F05-7E83-409B-A405-DC639AA56A4BQ36550000-840EBC88-C56D-4972-AB09-D85988D353D3
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Histologic subtypes of ovarian carcinoma: an overview.
@en
Histologic subtypes of ovarian carcinoma: an overview.
@nl
type
label
Histologic subtypes of ovarian carcinoma: an overview.
@en
Histologic subtypes of ovarian carcinoma: an overview.
@nl
prefLabel
Histologic subtypes of ovarian carcinoma: an overview.
@en
Histologic subtypes of ovarian carcinoma: an overview.
@nl
P1476
Histologic subtypes of ovarian carcinoma: an overview
@en
P2093
Robert A Soslow
P304
P356
10.1097/PGP.0B013E31815EA812
P577
2008-04-01T00:00:00Z